Disclaimers Do Not Remedy Content Violations – FDA Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
Providing disclaimers for material that promotes an uncleared or unapproved use does not remedy content violations, FDA's device center Promotion and Policy Staff emphasize in a Nov. 5 letter to Diomed